Three oral and 12 poster presentations demonstrate breadth and progress of AskBio’s gene therapy research and development ...

The 20th annual John Heinrichs Scholarly and Creative Activity Days (SACAD) was held on April 24. Despite an early threat of ...

Discover groundbreaking research and presentations from leading companies at the ARVO 2025 Annual Meeting, advancing ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Codexis to showcase data that demonstrate the scalability and reproducibility of its enzymatic siRNA manufacturing processes Three CDMO presentations to feature data on performance of Codexis ...

Mana.bio, a biotechnology company leveraging artificial intelligence (AI) and nanotechnology for targeted RNA delivery, today announced three poster presentations at the American Society of Gene & ...

In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...

Six posters presented at the American Association for Cancer Research (AACR) annual meetingAppointment of Dr. Sabeen Mekan as Senior Vice President, Clinical DevelopmentReported $321.6 million in cash ...

The event is organised in collaboration with leading national organisations including DRDO, ISRO, DAE and IITH ...

AI Proteins, a biotechnology company pioneering the development of de novo designed miniprotein therapeutics, will be sending four key scientists to present at PEGS Boston 2025, the leading ...

The Council of Europe project “Supporting democratic post-war elections in Ukraine – Phase II” (hereinafter “the Project”), ...